Age-related B cell dysfunction at the aging-cancer nexus: from shared manifestations to therapeutic potential
Cancer Letters · 2026-06 · 647 · 218436
DOI: 10.1016/j.canlet.2026.218436 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Cancer Letters, 2026-06. Verfasst von Luo-Tian Liu und 4 weiteren Autor:innen. Beteiligte Einrichtung: Key Laboratory of Breast Cancer in Shanghai, Department of Breast Surgery, Fudan University Shanghai Cancer Center, Shanghai 200032, China; Departmen…. Hauptthemen laut MEDLINE: Aging, B-Lymphocytes, Neoplasms. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 202 Literaturangaben. Gefördert von: National Key Research and Development Program of China, Shanghai Municipal Education Commission, Beijing Xisike Clinical Oncology Research Foundation.
Abstract (Originalsprache)
Aging and cancer are intricately linked through complex, bidirectional interactions, with immune remodeling representing a central point of convergence. Although studies of immune aging have largely centered on T cells, accumulating evidence indicates that B cells also undergo significant functional or phenotypic alterations during aging and tumorigenesis. Here, we introduce the concept of age-related B cell dysfunction to encompass a spectrum of changes that include impaired germinal center response, decline in B cell diversity, expansion of pro-inflammatory phenotypes, and increased autoreactivity. Aging and cancer share fundamental biological hallmarks, including genomic instability, epigenetic reprogramming, chronic inflammation, and dysbiosis, which profoundly reshape immune cell states. In this review, we synthesize emerging mechanistic evidence linking these processes to maladaptive B cell programs across tissues and tumor contexts, and discuss how such alterations influence tumor evolution, responses to therapy, and treatment-related toxicities. Finally, we highlight emerging strategies targeting age-related dysfunctional B cells in cancer, illustrating how insights from biology of aging and tumor immunology could inform future translational approaches.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Key Laboratory of Breast Cancer in Shanghai, Department of Breast Surgery, Fudan University Shanghai Cancer Center, Shanghai 200032, China; Department of Oncology, Shanghai Medical College, Fudan University, Shanghai 20…
Förderung
- National Key Research and Development Program of China
- Shanghai Municipal Education Commission
- Beijing Xisike Clinical Oncology Research Foundation
- Shanghai Municipal Health Commission
- Ministry of Science and Technology of the People's Republic of China
- National Natural Science Foundation of China
Zitieren
APA
Liu, L. T., Wang, H., Zhang, S. W., Shao, Z. M., & Jiang, Y. Z. (2026). Age-related B cell dysfunction at the aging-cancer nexus: from shared manifestations to therapeutic potential. Cancer Letters, 647, 218436. https://doi.org/10.1016/j.canlet.2026.218436
Vancouver
Liu LT, Wang H, Zhang SW, Shao ZM, Jiang YZ. Age-related B cell dysfunction at the aging-cancer nexus: from shared manifestations to therapeutic potential. Cancer Letters. 2026;647:218436. doi:10.1016/j.canlet.2026.218436
BibTeX
@article{Liu2026,
author = {Liu, Luo-Tian and Wang, Han and Zhang, Si-Wei and Shao, Zhi-Ming and Jiang, Yi-Zhou},
title = {Age-related B cell dysfunction at the aging-cancer nexus: from shared manifestations to therapeutic potential},
journal = {Cancer Letters},
year = {2026},
volume = {647},
pages = {218436},
doi = {10.1016/j.canlet.2026.218436}
}
EUVIMED